Centre Hospitalier Universitaire(CHU) de Toulouse

Toulouse 31300

0 studies enrolling now · 2 studies all time

What they study most

Advanced Systemic Mastocytosis (AdvSM), Aggressive Systemic Mastocytosis (ASM), High-risk Large B-cell Lymphoma (LBCL), Mast Cell Leukemia (MCL), SM With an Associated Hematologic Neoplasm (SM-AHN)

Studies at this site

• (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis — Recruiting now
• Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma — Running, not enrolling